by Rhoda Wilson, Expose News:
The covid and SARS pandemics were deliberately released from laboratories at the behest of pharmaceutical giants and governments, with the goal of profiting from the sale of vaccines and treatments.
Donald Rumsfeld, a former US Secretary of Defence, is identified as a key figure in this scheme, with ties to pharmaceutical companies such as Gilead Sciences and Searle Pharmaceuticals.
Rumsfeld’s connections to these companies and his role in shaping US policy on bio-defence and pandemic preparedness provide evidence of a corrupt system in which pharmaceutical giants and governments collaborate to engineer viral problems and peddle therapeutic solutions for profit.
Pharmaceutical companies and financial institutions have profited significantly from the covid pandemic, with Rumsfeld’s business model of “create the problem, then profit from the solution” being present throughout.
TRUTH LIVES on at https://sgtreport.tv/
Like countless others, I’ve been obsessed with the mystery of where covid truly originated. As a troubleshooter, I couldn’t resist jumping into the heated debate over its origins. Instead of following the well-trodden paths of lab leaks and wet markets, I wanted to take a different angle: an unseen “hand of capital” that is pulling the strings behind the scenes.
Over the past few years, I’ve sifted through an overwhelming number of articles, research papers and government reports about this topic. The deeper I dug, the clearer the answer began to emerge. After piecing all these details together, I uncovered something more interesting and closer to the truth. I contended that the two global pandemics of the 21st century, namely, SARS and covid-19, were deliberately released from laboratories at the behest of pharmaceutical giants and governments.
Thus emerged a fraudulent recombinant coronavirus industry that capitalised on human lives. The mechanism operates as follows: Pharmaceutical giants (e.g. Gilead, Moderna, Pfizer) propped up politicians to positions of power. These captured officials then enable pharmaceutical giants to simultaneously engineer viral problems and peddle therapeutic solutions. After amassing obscene profits, these corporations reinvest in political patronage to perpetuate their interests, ultimately forming a closed-loop Möbius strip of corruption.
Table of Contents
Spokesman of Pharmaceutical Giants: Donald H. Rumsfeld[1]
With the help of Searle Pharmaceuticals, an established pharmaceutical company now owned by Pfizer, Donald Rumsfeld launched his political career and later ascended to the throne of power.
In 1962, after serving as a staff assistant to Congressman Robert P. Griffin of Michigan and engaging and in a two-year stint with an investment banking firm, A. G. Becker & Co., Rumsfeld, at the age of 30, was handpicked by Searle’s chairman Daniel C. Searle and was appointed to the corporate board. From 1962 to 1968, Rumsfeld successfully served four terms in the US House of Representatives with Daniel’s support. In 1975, he was chosen by Ford to succeed James Schlesinger as United States Secretary of Defence.[2] During his time at Searle Pharmaceuticals, Rumsfeld played a key role in transforming the company from a small family business into a competitive player in the pharmaceutical industry. He also leveraged his political connections to lobby for legislation that would benefit Searle’s business interests, including policies on drug patents and food safety regulations. In 1985, Rumsfeld brokered Monsanto’s $2.7 billion takeover of Searle Pharmaceuticals.[3]
In 1988, Rumsfeld was recruited by Michael L. Riordan, the founder of the bio-pharmaceutical startup Gilead Sciences, to join the company’s board of directors. Rumsfeld left Gilead Sciences in 1990 and came back in 1993. Until 2001, he was once again propelled into high office, this time as US Secretary of Defence under President George W. Bush.
Another explosion is unlikely to strike the exact same spot. However, the same storyline happened twice in Rumsfeld’s career. Is this just a coincidence, or is there something more behind it?
Lucrative Business Opportunities
Then, the 9/11 attacks hit in 2001: a tragic event that plunged the nation into a state of panic and fear. In the wake of the catastrophe, the US government poured massive emergency funds into national security measures, including biological threat preparedness. For Rumsfeld, this was nothing short of a fiscal windfall. The influx of money dedicated to bio-defence initiatives, particularly in the context of potential biological attacks, aligned perfectly with his personal and corporate interests. It was an opportunity he seized with remarkable astuteness.
Notably, Gilead Sciences was the developer of Oseltamivir, a drug used to treat avian influenza as well as influenza A and B in humans. During Rumsfeld’s time as chairman of Gilead from 1997 to 2001, one of his key roles was to help bring antiviral drugs, including Oseltamivir, to international markets. However, at that time, Gilead was struggling financially; the company was losing money until 2003. As a two-time recipient of the Pharmaceutical Industry’s Outstanding CEO Award, Rumsfeld faced a serious challenge and was in desperate need of a way to “turn the tide”.[4]
The events of 9/11 presented a once-in-a-lifetime chance for Rumsfeld. He saw a new business opportunity: creating a virus while simultaneously producing a vaccine. This strategy would not only meet the country’s need for defence against biological threats but also allow it to profit from the widespread sale of vaccines, fuelled by the public’s fear of unknown dangers.
Bypassing Regulations
With ample startup capital and a suitable business model, the next challenge for Rumsfeld was to find ways to navigate regulations and ensure the business runs smoothly. It is as easy as pie for the veteran politician and businessman.
“Rumsfeld afforded me a close-up look at a special Washington phenomenon: the skilled full-time politician-bureaucrat in whom ambition, ability and substance fuse seamlessly,” former Secretary of State Henry Kissinger wrote in his memoirs.[5]
To avoid regulations, Rumsfeld urged the Bush government to exploit the “loophole” in Article X of the Biological Weapons Convention (“BWC“):
The States Parties to this Convention undertake to facilitate, and have the right to participate in, the fullest possible exchange of equipment, materials and scientific and technological information for the use of bacteriological (biological) agents and toxins for peaceful purposes. Parties to the Convention in a position to do so shall also co-operate in contributing individually or together with other States or international organisations to the further development and application of scientific discoveries in the field of bacteriology (biology) for the prevention of disease, or for other peaceful purposes.
He also insisted on vetoing the BWC’s draft verification protocol, citing “threats to trade secrets” which prevented effective verification of the biological weapons ban across the countries involved until today.
